Gregory D. Davis

Head of Research & Technology, SANGAMO THERAPEUTICS, INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 25, 2026Shares withheld for tax 1,630 shares at $0.17 of SANGAMO THERAPEUTICS, INC²
Apr 22, 2026Sold 69,827 shares at $0.25 of SANGAMO THERAPEUTICS, INC³
Feb 25, 2026Shares withheld for tax 5,119 shares at $0.47 of SANGAMO THERAPEUTICS, INC⁴
Feb 24, 2026Shares withheld for tax 832 shares at $0.47 of SANGAMO THERAPEUTICS, INC⁴
Jan 22, 2026Shares withheld for tax 7,721 shares at $0.40 of SANGAMO THERAPEUTICS, INC⁵
Nov 24, 2025Shares withheld for tax 723 shares at $0.42 of SANGAMO THERAPEUTICS, INC⁶
Oct 22, 2025Shares withheld for tax 6,708 shares at $0.66 of SANGAMO THERAPEUTICS, INC⁷
Aug 24, 2025Shares withheld for tax 723 shares at $0.59 of SANGAMO THERAPEUTICS, INC⁸
Jul 22, 2025Shares withheld for tax 6,708 shares at $0.48 of SANGAMO THERAPEUTICS, INC⁹
May 24, 2025Shares withheld for tax 723 shares at $0.47 of SANGAMO THERAPEUTICS, INC¹⁰
Apr 22, 2025Shares withheld for tax 6,708 shares at $0.78 of SANGAMO THERAPEUTICS, INC¹¹
Feb 25, 2025Granted 49,726 shares of SANGAMO THERAPEUTICS, INC¹²
Feb 25, 2025Shares withheld for tax 507 shares at $0.96 of SANGAMO THERAPEUTICS, INC¹²
Feb 24, 2025Shares withheld for tax 705 shares at $1.00 of SANGAMO THERAPEUTICS, INC¹²
Jan 22, 2025Shares withheld for tax 30,456 shares at $1.15 of SANGAMO THERAPEUTICS, INC¹³
Nov 25, 2024Shares withheld for tax 505 shares at $1.94 of SANGAMO THERAPEUTICS, INC¹⁴
Nov 24, 2024Shares withheld for tax 721 shares at $1.88 of SANGAMO THERAPEUTICS, INC¹⁴

The numbers on this page point here. Each one links to the record it came from.